Search - tctmd.com

Displaying 361 - 380 of 2254

Sort: Relevancy | Date

News Daily News

三联疗法特别是普拉格雷会增加急性心梗患者的出血风险

Yael L. Maxwell

December 22, 2015

News Daily News

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Yael L. Maxwell

December 22, 2015

News Daily News

This Study Has No Teeth: STABILITY Analysis Strengthens Link Between Periodontal, CV Disease

Shelley Wood

December 22, 2015

News Daily News

Estudio sobre la Pérdida de Dientes: Un Análisis del STABILITY Confirma el Nexo existente entre Enfermedad Periodontal y CV

Shelley Wood

December 22, 2015

News Daily News

El Tratamiento Triple, sobre todo con Prasugrel, Aumenta el Riesgo Hemorrágico de los IAM

Yael L. Maxwell

December 22, 2015

News Industry News

Cardiome Files New Drug Submission Seeking Canadian Approval of intravenous vernakalant

December 22, 2015

News Daily News

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

L.A. McKeown

December 21, 2015

News Daily News

La Reparación Mitral Percutánea parece Duradera y Segura en los Resultados a 5 Años del EVEREST II

L.A. McKeown

December 21, 2015

News Daily News

Early Studies Linking Gut Bacteria to Atherosclerosis, Offer Tantalizing Glimpse at New Drug Target

Michael O'Riordan

December 21, 2015

News Daily News

介入试验中可能需要将培训与新技术并重，才能实现最佳内科治疗

Todd Neale

December 20, 2015

News Daily News

For Interventional Trials, Optimal Medical Management May Entail as Much Training as New Techniques

Todd Neale

December 20, 2015

News Daily News

En los Ensayos Intervencionistas el Tratamiento Médico Óptimo podría acarrear Formación y Técnicas Nuevas

Todd Neale

December 20, 2015

News Daily News

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Caitlin E. Cox

December 20, 2015

News Daily News

Un Subestudio del CvLPRIT Halla Pequeños Daños Pasajeros en PCI de Arterias No Infartada

Caitlin E. Cox

December 15, 2015

News Industry News

First Patients Enrolled in the Gore RELINE MAX Clinical Study

December 15, 2015

News Daily News

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

L.A. McKeown

December 14, 2015

News Daily News

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Yael L. Maxwell

December 14, 2015

Presentation

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Presenter: Vivek Y. Reddy

December 13, 2015

News Daily News

Societies Issue Recommendations for Operators, Institutions Offering LAA Closure Procedures

L.A. McKeown

December 10, 2015

News Daily News

Las Sociedades Publican Recomendaciones para que Operadores y Centros Ofrezcan Intervenciones para el Cierre del AAI

L.A. McKeown

December 10, 2015

Advertisement

三联疗法特别是普拉格雷会增加急性心梗患者的出血风险

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

This Study Has No Teeth: STABILITY Analysis Strengthens Link Between Periodontal, CV Disease

Estudio sobre la Pérdida de Dientes: Un Análisis del STABILITY Confirma el Nexo existente entre Enfermedad Periodontal y CV

El Tratamiento Triple, sobre todo con Prasugrel, Aumenta el Riesgo Hemorrágico de los IAM

Cardiome Files New Drug Submission Seeking Canadian Approval of intravenous vernakalant

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

La Reparación Mitral Percutánea parece Duradera y Segura en los Resultados a 5 Años del EVEREST II

Early Studies Linking Gut Bacteria to Atherosclerosis, Offer Tantalizing Glimpse at New Drug Target

介入试验中可能需要将培训与新技术并重，才能实现最佳内科治疗

For Interventional Trials, Optimal Medical Management May Entail as Much Training as New Techniques

En los Ensayos Intervencionistas el Tratamiento Médico Óptimo podría acarrear Formación y Técnicas Nuevas

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Un Subestudio del CvLPRIT Halla Pequeños Daños Pasajeros en PCI de Arterias No Infartada

First Patients Enrolled in the Gore RELINE MAX Clinical Study

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Societies Issue Recommendations for Operators, Institutions Offering LAA Closure Procedures

Las Sociedades Publican Recomendaciones para que Operadores y Centros Ofrezcan Intervenciones para el Cierre del AAI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content